Global Parkinson's Disease Market Research Report 2023

Report ID: 1900863 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Parkinson's Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Carbidopa/Levodopa
        1.2.3 Dopamine Receptor Agonists
        1.2.4 MAO-Inhibitors
    1.3 Market by Application
        1.3.1 Global Parkinson's Disease Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals
        1.3.3 Clinics
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Parkinson's Disease Market Perspective (2018-2029)
    2.2 Parkinson's Disease Growth Trends by Region
        2.2.1 Global Parkinson's Disease Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Parkinson's Disease Historic Market Size by Region (2018-2023)
        2.2.3 Parkinson's Disease Forecasted Market Size by Region (2024-2029)
    2.3 Parkinson's Disease Market Dynamics
        2.3.1 Parkinson's Disease Industry Trends
        2.3.2 Parkinson's Disease Market Drivers
        2.3.3 Parkinson's Disease Market Challenges
        2.3.4 Parkinson's Disease Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Parkinson's Disease Players by Revenue
        3.1.1 Global Top Parkinson's Disease Players by Revenue (2018-2023)
        3.1.2 Global Parkinson's Disease Revenue Market Share by Players (2018-2023)
    3.2 Global Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Parkinson's Disease Revenue
    3.4 Global Parkinson's Disease Market Concentration Ratio
        3.4.1 Global Parkinson's Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Revenue in 2022
    3.5 Parkinson's Disease Key Players Head office and Area Served
    3.6 Key Players Parkinson's Disease Product Solution and Service
    3.7 Date of Enter into Parkinson's Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Breakdown Data by Type
    4.1 Global Parkinson's Disease Historic Market Size by Type (2018-2023)
    4.2 Global Parkinson's Disease Forecasted Market Size by Type (2024-2029)
5 Parkinson's Disease Breakdown Data by Application
    5.1 Global Parkinson's Disease Historic Market Size by Application (2018-2023)
    5.2 Global Parkinson's Disease Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Parkinson's Disease Market Size (2018-2029)
    6.2 North America Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Parkinson's Disease Market Size by Country (2018-2023)
    6.4 North America Parkinson's Disease Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Parkinson's Disease Market Size (2018-2029)
    7.2 Europe Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Parkinson's Disease Market Size by Country (2018-2023)
    7.4 Europe Parkinson's Disease Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Parkinson's Disease Market Size (2018-2029)
    8.2 Asia-Pacific Parkinson's Disease Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Parkinson's Disease Market Size by Region (2018-2023)
    8.4 Asia-Pacific Parkinson's Disease Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Parkinson's Disease Market Size (2018-2029)
    9.2 Latin America Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Parkinson's Disease Market Size by Country (2018-2023)
    9.4 Latin America Parkinson's Disease Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Parkinson's Disease Market Size (2018-2029)
    10.2 Middle East & Africa Parkinson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Parkinson's Disease Market Size by Country (2018-2023)
    10.4 Middle East & Africa Parkinson's Disease Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Teva
        11.1.1 Teva Company Detail
        11.1.2 Teva Business Overview
        11.1.3 Teva Parkinson's Disease Introduction
        11.1.4 Teva Revenue in Parkinson's Disease Business (2018-2023)
        11.1.5 Teva Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Parkinson's Disease Introduction
        11.2.4 Novartis Revenue in Parkinson's Disease Business (2018-2023)
        11.2.5 Novartis Recent Development
    11.3 GSK
        11.3.1 GSK Company Detail
        11.3.2 GSK Business Overview
        11.3.3 GSK Parkinson's Disease Introduction
        11.3.4 GSK Revenue in Parkinson's Disease Business (2018-2023)
        11.3.5 GSK Recent Development
    11.4 AbbVie
        11.4.1 AbbVie Company Detail
        11.4.2 AbbVie Business Overview
        11.4.3 AbbVie Parkinson's Disease Introduction
        11.4.4 AbbVie Revenue in Parkinson's Disease Business (2018-2023)
        11.4.5 AbbVie Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Parkinson's Disease Introduction
        11.5.4 Merck Revenue in Parkinson's Disease Business (2018-2023)
        11.5.5 Merck Recent Development
    11.6 Boehringer Ingelheim
        11.6.1 Boehringer Ingelheim Company Detail
        11.6.2 Boehringer Ingelheim Business Overview
        11.6.3 Boehringer Ingelheim Parkinson's Disease Introduction
        11.6.4 Boehringer Ingelheim Revenue in Parkinson's Disease Business (2018-2023)
        11.6.5 Boehringer Ingelheim Recent Development
    11.7 Amneal + Impax
        11.7.1 Amneal + Impax Company Detail
        11.7.2 Amneal + Impax Business Overview
        11.7.3 Amneal + Impax Parkinson's Disease Introduction
        11.7.4 Amneal + Impax Revenue in Parkinson's Disease Business (2018-2023)
        11.7.5 Amneal + Impax Recent Development
    11.8 Lundbeck
        11.8.1 Lundbeck Company Detail
        11.8.2 Lundbeck Business Overview
        11.8.3 Lundbeck Parkinson's Disease Introduction
        11.8.4 Lundbeck Revenue in Parkinson's Disease Business (2018-2023)
        11.8.5 Lundbeck Recent Development
    11.9 Sun Pharma
        11.9.1 Sun Pharma Company Detail
        11.9.2 Sun Pharma Business Overview
        11.9.3 Sun Pharma Parkinson's Disease Introduction
        11.9.4 Sun Pharma Revenue in Parkinson's Disease Business (2018-2023)
        11.9.5 Sun Pharma Recent Development
    11.10 Wockhardt
        11.10.1 Wockhardt Company Detail
        11.10.2 Wockhardt Business Overview
        11.10.3 Wockhardt Parkinson's Disease Introduction
        11.10.4 Wockhardt Revenue in Parkinson's Disease Business (2018-2023)
        11.10.5 Wockhardt Recent Development
    11.11 UCB
        11.11.1 UCB Company Detail
        11.11.2 UCB Business Overview
        11.11.3 UCB Parkinson's Disease Introduction
        11.11.4 UCB Revenue in Parkinson's Disease Business (2018-2023)
        11.11.5 UCB Recent Development
    11.12 Bausch Health
        11.12.1 Bausch Health Company Detail
        11.12.2 Bausch Health Business Overview
        11.12.3 Bausch Health Parkinson's Disease Introduction
        11.12.4 Bausch Health Revenue in Parkinson's Disease Business (2018-2023)
        11.12.5 Bausch Health Recent Development
    11.13 Acadia
        11.13.1 Acadia Company Detail
        11.13.2 Acadia Business Overview
        11.13.3 Acadia Parkinson's Disease Introduction
        11.13.4 Acadia Revenue in Parkinson's Disease Business (2018-2023)
        11.13.5 Acadia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Parkinson's Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Carbidopa/Levodopa
    Table 3. Key Players of Dopamine Receptor Agonists
    Table 4. Key Players of MAO-Inhibitors
    Table 5. Global Parkinson's Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Parkinson's Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Parkinson's Disease Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Parkinson's Disease Market Share by Region (2018-2023)
    Table 9. Global Parkinson's Disease Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Parkinson's Disease Market Share by Region (2024-2029)
    Table 11. Parkinson's Disease Market Trends
    Table 12. Parkinson's Disease Market Drivers
    Table 13. Parkinson's Disease Market Challenges
    Table 14. Parkinson's Disease Market Restraints
    Table 15. Global Parkinson's Disease Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Parkinson's Disease Market Share by Players (2018-2023)
    Table 17. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease as of 2022)
    Table 18. Ranking of Global Top Parkinson's Disease Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Parkinson's Disease Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Parkinson's Disease Product Solution and Service
    Table 22. Date of Enter into Parkinson's Disease Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Parkinson's Disease Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Parkinson's Disease Revenue Market Share by Type (2018-2023)
    Table 26. Global Parkinson's Disease Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Parkinson's Disease Revenue Market Share by Type (2024-2029)
    Table 28. Global Parkinson's Disease Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Parkinson's Disease Revenue Market Share by Application (2018-2023)
    Table 30. Global Parkinson's Disease Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Parkinson's Disease Revenue Market Share by Application (2024-2029)
    Table 32. North America Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Parkinson's Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Parkinson's Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Parkinson's Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Parkinson's Disease Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Parkinson's Disease Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Parkinson's Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Parkinson's Disease Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Parkinson's Disease Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Teva Company Detail
    Table 48. Teva Business Overview
    Table 49. Teva Parkinson's Disease Product
    Table 50. Teva Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 51. Teva Recent Development
    Table 52. Novartis Company Detail
    Table 53. Novartis Business Overview
    Table 54. Novartis Parkinson's Disease Product
    Table 55. Novartis Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 56. Novartis Recent Development
    Table 57. GSK Company Detail
    Table 58. GSK Business Overview
    Table 59. GSK Parkinson's Disease Product
    Table 60. GSK Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 61. GSK Recent Development
    Table 62. AbbVie Company Detail
    Table 63. AbbVie Business Overview
    Table 64. AbbVie Parkinson's Disease Product
    Table 65. AbbVie Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 66. AbbVie Recent Development
    Table 67. Merck Company Detail
    Table 68. Merck Business Overview
    Table 69. Merck Parkinson's Disease Product
    Table 70. Merck Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 71. Merck Recent Development
    Table 72. Boehringer Ingelheim Company Detail
    Table 73. Boehringer Ingelheim Business Overview
    Table 74. Boehringer Ingelheim Parkinson's Disease Product
    Table 75. Boehringer Ingelheim Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 76. Boehringer Ingelheim Recent Development
    Table 77. Amneal + Impax Company Detail
    Table 78. Amneal + Impax Business Overview
    Table 79. Amneal + Impax Parkinson's Disease Product
    Table 80. Amneal + Impax Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 81. Amneal + Impax Recent Development
    Table 82. Lundbeck Company Detail
    Table 83. Lundbeck Business Overview
    Table 84. Lundbeck Parkinson's Disease Product
    Table 85. Lundbeck Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 86. Lundbeck Recent Development
    Table 87. Sun Pharma Company Detail
    Table 88. Sun Pharma Business Overview
    Table 89. Sun Pharma Parkinson's Disease Product
    Table 90. Sun Pharma Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 91. Sun Pharma Recent Development
    Table 92. Wockhardt Company Detail
    Table 93. Wockhardt Business Overview
    Table 94. Wockhardt Parkinson's Disease Product
    Table 95. Wockhardt Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 96. Wockhardt Recent Development
    Table 97. UCB Company Detail
    Table 98. UCB Business Overview
    Table 99. UCB Parkinson's Disease Product
    Table 100. UCB Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 101. UCB Recent Development
    Table 102. Bausch Health Company Detail
    Table 103. Bausch Health Business Overview
    Table 104. Bausch Health Parkinson's Disease Product
    Table 105. Bausch Health Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 106. Bausch Health Recent Development
    Table 107. Acadia Company Detail
    Table 108. Acadia Business Overview
    Table 109. Acadia Parkinson's Disease Product
    Table 110. Acadia Revenue in Parkinson's Disease Business (2018-2023) & (US$ Million)
    Table 111. Acadia Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Parkinson's Disease Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Parkinson's Disease Market Share by Type: 2022 VS 2029
    Figure 3. Carbidopa/Levodopa Features
    Figure 4. Dopamine Receptor Agonists Features
    Figure 5. MAO-Inhibitors Features
    Figure 6. Global Parkinson's Disease Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Parkinson's Disease Market Share by Application: 2022 VS 2029
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Parkinson's Disease Report Years Considered
    Figure 11. Global Parkinson's Disease Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Parkinson's Disease Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Parkinson's Disease Market Share by Region: 2022 VS 2029
    Figure 14. Global Parkinson's Disease Market Share by Players in 2022
    Figure 15. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Parkinson's Disease Revenue in 2022
    Figure 17. North America Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Parkinson's Disease Market Share by Country (2018-2029)
    Figure 19. United States Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Parkinson's Disease Market Share by Country (2018-2029)
    Figure 23. Germany Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Parkinson's Disease Market Share by Region (2018-2029)
    Figure 31. China Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Parkinson's Disease Market Share by Country (2018-2029)
    Figure 39. Mexico Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Parkinson's Disease Market Share by Country (2018-2029)
    Figure 43. Turkey Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Parkinson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Teva Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 46. Novartis Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 47. GSK Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 48. AbbVie Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 49. Merck Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 50. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 51. Amneal + Impax Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 52. Lundbeck Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 53. Sun Pharma Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 54. Wockhardt Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 55. UCB Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 56. Bausch Health Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 57. Acadia Revenue Growth Rate in Parkinson's Disease Business (2018-2023)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Amneal + Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Frequently Asked Questions
Parkinson's Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Parkinson's Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Parkinson's Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports